1. Abood, L.G., Lowy, K., Tometsko, A., and MacNeil, M., 1979, Evidence for a noncholinergic site for nicotine’s action in brain: psychopharmacological, electrophysiological and receptor binding studies. Arch. Int. Pharmacodyn. Ther. 237 213–229.
2. Andersen, P., Eccles, J.C., Loyning, Y., and Voorhoeve, P.E., 1963, Strychnine-resistant central inhibition. Nature 200: 843–845.
3. Bebbington, A., Brimblecombe, R.W., and Shakeshaft, D., 1966, The central and peripheral activity of acetylenic amines related to oxotremorine. Br. J. Pharmacol. 26: 56–67.
4. Birdsall, N.J.M., Burgen, A.S.V., and Hulme, E.C., 1978a, Correlation between the binding properties and pharmacological responses of muscarinic receptors. in Cholinergic Mechanisms and Psychopharmacology, Vol. 24, D.J. Jenden, ed., Plenum Press, New York.
5. Birdsall, N.J.M., Burgen, A.S.V., and Hulme, E.C., 1978b, The binding of agonists to brain muscarinic receptors. Mol. Pharmacol, 14: 723–736.